The global Encorafenib market size was valued at US$ 456.3 million in 2024 and is projected to reach US$ 782.9 million by 2030, at a CAGR of 9.4% during the forecast period 2024-2030.
United States Encorafenib market size was valued at US$ 213.7 million in 2024 and is projected to reach US$ 358.4 million by 2030, at a CAGR of 9.0% during the forecast period 2024-2030.
Encorafenib is a BRAF inhibitor used in combination therapy for the treatment of BRAF-mutant melanoma and colorectal cancer.
Strong growth driven by increasing adoption in BRAF-mutant cancers. Expanding indications in combination therapies enhancing market potential. Ongoing clinical trials for new indications and combinations boosting future prospects.
Report Overview
This report provides a deep insight into the global Encorafenib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Encorafenib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Encorafenib market in any manner.
Global Encorafenib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Market Segmentation (by Type)
- 50mg Capsules
- 75mg Capsules
Market Segmentation (by Application)
- Hospital
- Clinic
- Pharmacy
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Encorafenib Market
- Overview of the regional outlook of the Encorafenib Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Encorafenib
1.2 Key Market Segments
1.2.1 Encorafenib Segment by Type
1.2.2 Encorafenib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Encorafenib Market Overview
2.1 Global Market Overview
2.1.1 Global Encorafenib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Encorafenib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Encorafenib Market Competitive Landscape
3.1 Global Encorafenib Sales by Manufacturers (2019-2024)
3.2 Global Encorafenib Revenue Market Share by Manufacturers (2019-2024)
3.3 Encorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Encorafenib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Encorafenib Sales Sites, Area Served, Product Type
3.6 Encorafenib Market Competitive Situation and Trends
3.6.1 Encorafenib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Encorafenib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Encorafenib Industry Chain Analysis
4.1 Encorafenib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Encorafenib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Encorafenib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Encorafenib Sales Market Share by Type (2019-2024)
6.3 Global Encorafenib Market Size Market Share by Type (2019-2024)
6.4 Global Encorafenib Price by Type (2019-2024)
7 Encorafenib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Encorafenib Market Sales by Application (2019-2024)
7.3 Global Encorafenib Market Size (M USD) by Application (2019-2024)
7.4 Global Encorafenib Sales Growth Rate by Application (2019-2024)
8 Encorafenib Market Segmentation by Region
8.1 Global Encorafenib Sales by Region
8.1.1 Global Encorafenib Sales by Region
8.1.2 Global Encorafenib Sales Market Share by Region
8.2 North America
8.2.1 North America Encorafenib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Encorafenib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Encorafenib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Encorafenib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Encorafenib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Array BioPharma
9.1.1 Array BioPharma Encorafenib Basic Information
9.1.2 Array BioPharma Encorafenib Product Overview
9.1.3 Array BioPharma Encorafenib Product Market Performance
9.1.4 Array BioPharma Business Overview
9.1.5 Array BioPharma Encorafenib SWOT Analysis
9.1.6 Array BioPharma Recent Developments
10 Encorafenib Market Forecast by Region
10.1 Global Encorafenib Market Size Forecast
10.2 Global Encorafenib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Encorafenib Market Size Forecast by Country
10.2.3 Asia Pacific Encorafenib Market Size Forecast by Region
10.2.4 South America Encorafenib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Encorafenib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Encorafenib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Encorafenib by Type (2025-2030)
11.1.2 Global Encorafenib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Encorafenib by Type (2025-2030)
11.2 Global Encorafenib Market Forecast by Application (2025-2030)
11.2.1 Global Encorafenib Sales (Kilotons) Forecast by Application
11.2.2 Global Encorafenib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Encorafenib Market Size Comparison by Region (M USD)
Table 5. Global Encorafenib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Encorafenib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Encorafenib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Encorafenib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Encorafenib as of 2022)
Table 10. Global Market Encorafenib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Encorafenib Sales Sites and Area Served
Table 12. Manufacturers Encorafenib Product Type
Table 13. Global Encorafenib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Encorafenib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Encorafenib Market Challenges
Table 22. Global Encorafenib Sales by Type (Kilotons)
Table 23. Global Encorafenib Market Size by Type (M USD)
Table 24. Global Encorafenib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Encorafenib Sales Market Share by Type (2019-2024)
Table 26. Global Encorafenib Market Size (M USD) by Type (2019-2024)
Table 27. Global Encorafenib Market Size Share by Type (2019-2024)
Table 28. Global Encorafenib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Encorafenib Sales (Kilotons) by Application
Table 30. Global Encorafenib Market Size by Application
Table 31. Global Encorafenib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Encorafenib Sales Market Share by Application (2019-2024)
Table 33. Global Encorafenib Sales by Application (2019-2024) & (M USD)
Table 34. Global Encorafenib Market Share by Application (2019-2024)
Table 35. Global Encorafenib Sales Growth Rate by Application (2019-2024)
Table 36. Global Encorafenib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Encorafenib Sales Market Share by Region (2019-2024)
Table 38. North America Encorafenib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Encorafenib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Encorafenib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Encorafenib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Encorafenib Sales by Region (2019-2024) & (Kilotons)
Table 43. Array BioPharma Encorafenib Basic Information
Table 44. Array BioPharma Encorafenib Product Overview
Table 45. Array BioPharma Encorafenib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Array BioPharma Business Overview
Table 47. Array BioPharma Encorafenib SWOT Analysis
Table 48. Array BioPharma Recent Developments
Table 49. Global Encorafenib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Encorafenib Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Encorafenib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Encorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Encorafenib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Encorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Encorafenib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Encorafenib Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Encorafenib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Encorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Encorafenib Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Encorafenib Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Encorafenib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Encorafenib Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Encorafenib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Encorafenib Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Encorafenib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Encorafenib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Encorafenib Market Size (M USD), 2019-2030
Figure 5. Global Encorafenib Market Size (M USD) (2019-2030)
Figure 6. Global Encorafenib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Encorafenib Market Size by Country (M USD)
Figure 11. Encorafenib Sales Share by Manufacturers in 2023
Figure 12. Global Encorafenib Revenue Share by Manufacturers in 2023
Figure 13. Encorafenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Encorafenib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Encorafenib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Encorafenib Market Share by Type
Figure 18. Sales Market Share of Encorafenib by Type (2019-2024)
Figure 19. Sales Market Share of Encorafenib by Type in 2023
Figure 20. Market Size Share of Encorafenib by Type (2019-2024)
Figure 21. Market Size Market Share of Encorafenib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Encorafenib Market Share by Application
Figure 24. Global Encorafenib Sales Market Share by Application (2019-2024)
Figure 25. Global Encorafenib Sales Market Share by Application in 2023
Figure 26. Global Encorafenib Market Share by Application (2019-2024)
Figure 27. Global Encorafenib Market Share by Application in 2023
Figure 28. Global Encorafenib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Encorafenib Sales Market Share by Region (2019-2024)
Figure 30. North America Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Encorafenib Sales Market Share by Country in 2023
Figure 32. U.S. Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Encorafenib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Encorafenib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Encorafenib Sales Market Share by Country in 2023
Figure 37. Germany Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Encorafenib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Encorafenib Sales Market Share by Region in 2023
Figure 44. China Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Encorafenib Sales and Growth Rate (Kilotons)
Figure 50. South America Encorafenib Sales Market Share by Country in 2023
Figure 51. Brazil Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Encorafenib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Encorafenib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Encorafenib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Encorafenib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Encorafenib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Encorafenib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Encorafenib Market Share Forecast by Type (2025-2030)
Figure 65. Global Encorafenib Sales Forecast by Application (2025-2030)
Figure 66. Global Encorafenib Market Share Forecast by Application (2025-2030)
